We speculate that this is mainly because nuclear localization of GPSM2 is unavailable to inhibit activity of Gα protein that is expressed on the membrane, thereby enhancing the activity of the GPCR pathway and promoting tumor progression. The gene discussed is GPSM2; the disease is neoplasm.